According to Aurobindo Pharma
's latest financial reports the company has $0.89 Billion USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $0.75 B | 26.12% |
2022-03-31 | $0.60 B | -21.47% |
2021-03-31 | $0.76 B | 103.62% |
2020-03-31 | $0.37 B | 35.31% |
2019-03-31 | $0.27 B | 45.51% |
2018-03-31 | $0.19 B | 141.62% |
2017-03-31 | $79.01 M | -34.36% |
2016-03-31 | $0.12 B | 60.95% |
2015-03-31 | $74.78 M | 151.77% |
2014-03-31 | $29.7 M | -22.66% |
2013-03-31 | $38.4 M | 119.42% |
2012-03-31 | $17.5 M | -58.07% |
2011-03-31 | $41.74 M | 156.81% |
2010-03-31 | $16.25 M | -35.32% |
2009-03-31 | $25.13 M | -64.52% |
2008-03-31 | $70.83 M | -47.5% |
2007-03-31 | $0.13 B | 197.44% |
2006-03-31 | $45.36 M | 232.91% |
2005-03-31 | $13.62 M | -5.21% |
2004-03-31 | $14.37 M |